1. Clinical Overview
A topical fixed-dose combination antifungal and corticosteroid. Sertaconazole is a broad-spectrum imidazole antifungal with anti-inflammatory and antipruritic properties. Beclometasone dipropionate is a potent, medium-potency group III topical corticosteroid. The combination is primarily indicated for the treatment of fungal skin infections complicated by inflammation, pruritus, and eczematization, commonly seen in the Indian tropical climate.
| Onset | Duration | Bioavailability |
|---|---|---|
| Antipruritic and anti-inflammatory effects of beclometasone are typically observed within 24-48 hours. Antifungal symptom relief (reduced burning, itching) may begin within 3-5 days, but mycological cure requires full treatment course. | Local anti-inflammatory effects persist for several hours post-application. The fungistatic effect of sertaconazole lasts due to its accumulation in the stratum corneum, providing a post-antifungal effect. | Topical; negligible systemic absorption (<1% for sertaconazole, <2-5% for beclometasone) on intact skin. Absorption increases significantly on inflamed, broken, or occluded skin, or with application to large surface areas. |
2. Mechanism of Action
Sertaconazole exerts a dual fungistatic and fungicidal effect by inhibiting ergosterol biosynthesis in the fungal cell membrane via inhibition of lanosterol 14α-demethylase (CYP51). This leads to accumulation of toxic methylated sterols and depletion of ergosterol, disrupting membrane integrity and function. It also inhibits neutrophil chemotaxis, providing anti-inflammatory action. Beclometasone dipropionate is a prodrug activated to 17-BMP, which binds to glucocorticoid receptors, modulating gene transcription. This leads to synthesis of anti-inflammatory proteins (lipocortin) and inhibition of pro-inflammatory mediators (cytokines, leukotrienes, prostaglandins), resulting in vasoconstriction, reduced edema, and immunosuppression.
3. Indications & Uses
- Fungal skin infections with significant inflammation and itching (Dermatophytoses - Tinea corporis, Tinea cruris, Tinea pedis)
- Candidal intertrigo (Candida albicans infection in skin folds) with associated inflammation
- Seborrheic dermatitis (when secondary fungal infection by Malassezia is suspected)
- Mixed dermatoses with confirmed or suspected fungal component and eczematization
4. Dosage & Administration
Adult Dosage: Apply a thin film to the affected and immediately surrounding area twice daily (morning and evening). Gently massage until absorbed.
Administration: 1. Wash and dry the affected area thoroughly. 2. Take a small amount of cream on clean fingertip. 3. Apply a thin layer to cover the lesion and about 1-2 cm of surrounding normal skin. 4. Gently rub in until the cream disappears. 5. Wash hands after application unless hands are being treated. 6. Avoid occlusive dressings unless specifically directed by a physician. 7. Do not use for longer than prescribed.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation (usually transient)
- Itching at application site
- Dryness of skin
- Erythema
- Skin irritation
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Topical Corticosteroids (e.g., Clobetasol, Mometasone) | Additive risk of local and systemic adverse effects (atrophy, HPA suppression). | Major |
| Systemic Corticosteroids (e.g., Prednisolone, Dexamethasone) | Increased risk of hypercorticism and adrenal suppression. | Major |
| Topical Immunosuppressants (e.g., Tacrolimus, Pimecrolimus) | Potential increased risk of skin infection; concurrent use not recommended. | Moderate |
| Strong CYP3A4 Inhibitors (Systemic - e.g., Ketoconazole, Itraconazole, Ritonavir) | May theoretically inhibit metabolism of systemically absorbed beclometasone, increasing corticosteroid side effects. Risk is low with topical use on limited areas. | Theoretical/Minor |
7. Patient Counselling
- DO use exactly as prescribed by your doctor for the full prescribed length of time.
- DO wash and dry the area thoroughly before application.
- DO wash your hands after applying the cream (unless treating hands).
- DO report any worsening of symptoms, signs of new infection (increased redness, pus, swelling), or lack of improvement after 1-2 weeks.
- DON'T apply to the face, groin, or armpits unless specifically directed by your doctor.
- DON'T use occlusive dressings (plastic wraps, tight bandages) over the area unless advised.
- DON'T share your medication with others, even if they have similar symptoms.
- DON'T use for longer than 4 weeks continuously.
8. Toxicology & Storage
Overdose: Topical overdose manifests as severe local side effects: pronounced skin atrophy, striae, telangiectasia, ulceration, and signs of systemic corticosteroid absorption (hypercorticism: moon face, central obesity, hypertension, hyperglycemia, muscle weakness, adrenal insufficiency upon withdrawal).
Storage: Store at room temperature (15-25°C), in a cool, dry place. Protect from light and moisture. Do not freeze. Keep the tube tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.